---
title: "Overnight surged by 140%, short interest also surged! What happened to INVO?"
type: "News"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/202218249.md"
description: "Why did Invo Bioscience soar? Its fourth-quarter revenue increased by 396.15% year-on-year! As for short selling data, the number of shares shorted overnight skyrocketed from just a few thousand or hundred shares to nearly 7 million shares, with the volume of short selling transactions surging to tens of millions"
datetime: "2024-04-18T02:53:46.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/202218249.md)
  - [en](https://longbridge.com/en/news/202218249.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/202218249.md)
---

> 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/202218249.md) | [English](https://longbridge.com/en/news/202218249.md)


# Overnight surged by 140%, short interest also surged! What happened to INVO?

Overnight, Invo Bioscience's stock price surged by 375% at one point, ultimately closing up 140% with a price of $1.82.

On the news front, as a medical device company focusing on the Assisted Reproductive Technology (ART) market, Invo achieved a revenue of $1.382 million in the fourth quarter of 2023, up 396.15% year-on-year from $0.27814 million. The earnings per share were -$0.64, compared to the previous -$4.60.

However, it is worth noting that the short interest data for the stock skyrocketed overnight: the number of shares being shorted suddenly surged from a few thousand to nearly 7 million shares, with the volume of short sales soaring to tens of millions.

### 相關股票

- [NAYA Bioscience (NAYA.US)](https://longbridge.com/zh-HK/quote/NAYA.US.md)
- [INVO Fertility (IVF.US)](https://longbridge.com/zh-HK/quote/IVF.US.md)

## 相關資訊與研究

- [Jinxin Fertility Group FY 2025 Loss Spurs Debate On Premium Valuation Narratives](https://longbridge.com/zh-HK/news/280805363.md)
- [INVO Fertility Inc. Granted U.S. Patent for Modified INVOcell® Fertility Device](https://longbridge.com/zh-HK/news/275612613.md)
- [INVO Fertility Appoints Terah Krigsvold as CFO and Andrea Goren as Chief Business Officer](https://longbridge.com/zh-HK/news/271698098.md)
- [INVO Fertility Inc. Files Initial Statement of Beneficial Ownership for Chief Financial Officer Terah Renee Krigsvold](https://longbridge.com/zh-HK/news/272477616.md)